{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:49:02Z","timestamp":1790254142720,"version":"4.1.0"},"reference-count":47,"publisher":"American Diabetes Association","issue":"1","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:p>Oxidative stress plays a critical role in the pathogenesis of atherosclerosis in patients with metabolic syndrome. This study aimed to investigate whether a relationship exists between phagocytic NADPH oxidase activity and oxidative stress and atherosclerosis in metabolic syndrome patients. The study was performed in 56 metabolic syndrome patients (metabolic syndrome group), 99 patients with one or two cardiovascular risk factors (cardiovascular risk factor group), and 28 healthy subjects (control group). NADPH oxidase expression and activity was augmented (P &amp;lt; 0.05) in metabolic syndrome compared with cardiovascular risk factor and control groups. Insulin was enhanced (P &amp;lt; 0.05) in metabolic syndrome patients compared with cardiovascular risk factor and control groups and correlated with NADPH oxidase activity in the overall population. Insulin stimulated NADPH oxidase activity; this effect was abolished by a specific protein kinase C inhibitor. Oxidized LDL and nitrotyrosine levels and carotid intima-media thickness were increased (P &amp;lt; 0.05) in the metabolic syndrome group compared with cardiovascular risk factor and control groups and correlated with NADPH oxidase activity in the overall population. These findings suggest that phagocytic NADPH oxidase overactivity is involved in oxidative stress and atherosclerosis in metabolic syndrome patients. Our findings also suggest that hyperinsulinemia may contribute to oxidative stress in metabolic syndrome patients through activation of NADPH oxidase.<\/jats:p>","DOI":"10.2337\/diabetes.55.01.06.db05-0751","type":"journal-article","created":{"date-parts":[[2006,4,22]],"date-time":"2006-04-22T04:55:42Z","timestamp":1145681742000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":107,"title":["Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome"],"prefix":"10.2337","volume":"55","author":[{"given":"Ana","family":"Fortun\u0303o","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Sciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorka","family":"San Jose\u0301","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u0301a U.","family":"Moreno","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Beloqui","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Clinic, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Di\u0301ez","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain"},{"name":"Department of Cardiology and Cardiovascular Surgery, University Clinic, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Zalba","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031208444058300_R1","doi-asserted-by":"crossref","unstructured":"Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA\u2008287:356\u2013359,2002","DOI":"10.1001\/jama.287.3.356"},{"key":"2022031208444058300_R2","doi-asserted-by":"crossref","unstructured":"Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes\u200852:1210\u20131214,2003","DOI":"10.2337\/diabetes.52.5.1210"},{"key":"2022031208444058300_R3","doi-asserted-by":"crossref","unstructured":"Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA\u2008288:2709\u20132716,2002","DOI":"10.1001\/jama.288.21.2709"},{"key":"2022031208444058300_R4","doi-asserted-by":"crossref","unstructured":"Griendling KK, FitzGerald GA: Oxidative stress and cardiovascular injury. Part II: animal and human studies. Circulation\u2008108:2034\u20132040,2003","DOI":"10.1161\/01.CIR.0000093661.90582.c4"},{"key":"2022031208444058300_R5","doi-asserted-by":"crossref","unstructured":"Fortun\u0303o A, Oliva\u0301n S, Beloqui O, San Jose\u0301 G, Moreno MU, Di\u0301ez J, Zalba G: Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide production in essential hypertension. J Hypertens\u200822:2169\u20132175,2004","DOI":"10.1097\/00004872-200411000-00020"},{"key":"2022031208444058300_R6","doi-asserted-by":"crossref","unstructured":"Redo\u0301n J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Sa\u0301ez GT: Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension\u200841:1096\u20131101,2003","DOI":"10.1161\/01.HYP.0000068370.21009.38"},{"key":"2022031208444058300_R7","doi-asserted-by":"crossref","unstructured":"Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol\u200823:434\u2013439,2003","DOI":"10.1161\/01.ATV.0000058402.34138.11"},{"key":"2022031208444058300_R8","doi-asserted-by":"crossref","unstructured":"Bae JH, Bassenge E, Kim KB, Kim YN, Kim KS, Lee HJ, Moon KC, Lee MS, Park KY, Schwemmer M: Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis\u2008155:517\u2013523,2001","DOI":"10.1016\/S0021-9150(00)00601-8"},{"key":"2022031208444058300_R9","doi-asserted-by":"crossref","unstructured":"Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol\u200824:816\u2013823,2004","DOI":"10.1161\/01.ATV.0000122852.22604.78"},{"key":"2022031208444058300_R10","doi-asserted-by":"crossref","unstructured":"Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A: Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab\u200889:4963\u20134971,2004","DOI":"10.1210\/jc.2004-0305"},{"key":"2022031208444058300_R11","doi-asserted-by":"crossref","unstructured":"Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB: The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes\u200853:1068\u20131073,2004","DOI":"10.2337\/diabetes.53.4.1068"},{"key":"2022031208444058300_R12","doi-asserted-by":"crossref","unstructured":"Huang PL: Unraveling the links between diabetes, obesity and cardiovascular disease. Circ Res\u200896:1129\u20131131,2005","DOI":"10.1161\/01.RES.0000170705.56583.45"},{"key":"2022031208444058300_R13","doi-asserted-by":"crossref","unstructured":"Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF Jr, Penn MS, Sprecher DL, Vita JA, Hazen SL: Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA\u2008289:1675\u20131680,2003","DOI":"10.1001\/jama.289.13.1675"},{"key":"2022031208444058300_R14","doi-asserted-by":"crossref","unstructured":"Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol\u2008271:C1424\u2013C1437,1996","DOI":"10.1152\/ajpcell.1996.271.5.C1424"},{"key":"2022031208444058300_R15","doi-asserted-by":"crossref","unstructured":"Griendling KK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res\u200886:494\u2013501,2000","DOI":"10.1161\/01.RES.86.5.494"},{"key":"2022031208444058300_R16","doi-asserted-by":"crossref","unstructured":"Bokoch GM, Knaus UG: NADPH oxidases: not just for leukocytes anymore!Trends Biochem Sci\u200828:502\u2013508,2003","DOI":"10.1016\/S0968-0004(03)00194-4"},{"key":"2022031208444058300_R17","doi-asserted-by":"crossref","unstructured":"Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM: Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res\u200886:E85\u2013E90,2000","DOI":"10.1161\/01.RES.86.9.e85"},{"key":"2022031208444058300_R18","doi-asserted-by":"crossref","unstructured":"Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y, Itoh H, Yokoyama M: Expression of NADH\/NADPH oxidase p22phox in human coronary arteries. Circulation\u2008100:1494\u20131498,1999","DOI":"10.1161\/01.CIR.100.14.1494"},{"key":"2022031208444058300_R19","doi-asserted-by":"crossref","unstructured":"Kalinina N, Agrotis A, Tararak E, Antropova Y, Kanellakis P, Ilyinskaya O, Quinn MT, Smirnov V, Bobik A: Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol\u200822:2037\u20132043,2002","DOI":"10.1161\/01.ATV.0000040222.02255.0F"},{"key":"2022031208444058300_R20","doi-asserted-by":"crossref","unstructured":"Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK: Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation\u2008105:1429\u20131435,2002","DOI":"10.1161\/01.CIR.0000012917.74432.66"},{"key":"2022031208444058300_R21","doi-asserted-by":"crossref","unstructured":"Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, Awano K, Kobayashi K, Maeda K, Hata K, Shinke T, Kobayashi S, Hirata K, Kawashima S, Itabe H, Hayashi Y, Imajoh-Ohmi S, Itoh H, Yokoyama M: Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol\u200822:1838\u20131844,2002","DOI":"10.1161\/01.ATV.0000037101.40667.62"},{"key":"2022031208444058300_R22","doi-asserted-by":"crossref","unstructured":"Zalba G, Beloqui O, San Jose\u0301 G, Moreno MU, Fortun\u0303o A, Di\u0301ez J: NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol\u200825:1452\u20131457,2005","DOI":"10.1161\/01.ATV.0000168411.72483.08"},{"key":"2022031208444058300_R23","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA\u2008285:2486\u20132497,2001","DOI":"10.1001\/jama.285.19.2486"},{"key":"2022031208444058300_R24","doi-asserted-by":"crossref","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest\u2008114:1752\u20131761,2004","DOI":"10.1172\/JCI21625"},{"key":"2022031208444058300_R25","doi-asserted-by":"crossref","unstructured":"Zalba G, San Jose\u0301 G, Moreno MU, Fortun\u0303o MA, Fortun\u0303o A, Beaumont FJ, Di\u0301ez J: Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension\u200838:1395\u20131399,2001","DOI":"10.1161\/hy1201.099611"},{"key":"2022031208444058300_R26","doi-asserted-by":"crossref","unstructured":"Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation\u2008105:1656\u20131662,2002","DOI":"10.1161\/01.CIR.0000012748.58444.08"},{"key":"2022031208444058300_R27","doi-asserted-by":"crossref","unstructured":"Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R: Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation\u2008111:1448\u20131454,2005","DOI":"10.1161\/01.CIR.0000158483.13093.9D"},{"key":"2022031208444058300_R28","doi-asserted-by":"crossref","unstructured":"Zhuang D, Ceacareanu AC, Lin Y, Ceacareanu B, Dixit M, Chapman KE, Waters CM, Rao GN, Hassid A: Nitric oxide attenuates insulin- or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H2O2 levels: essential role of cGMP. Am J Physiol Heart Circ Physiol\u2008286:H2103\u2013H2112,2004","DOI":"10.1152\/ajpheart.01118.2003"},{"key":"2022031208444058300_R29","doi-asserted-by":"crossref","unstructured":"Ceolotto G, Bevilacqua M, Papparella I, Baritono E, Franco L, Corvaja C, Mazzoni M, Semplicini A, Avogaro A: Insulin generates free radicals by an NAD(P)H, phosphatidylinositol 3\u2032-kinase\u2013dependent mechanism in human skin fibroblasts ex vivo. Diabetes\u200853:1344\u20131351,2004","DOI":"10.2337\/diabetes.53.5.1344"},{"key":"2022031208444058300_R30","doi-asserted-by":"crossref","unstructured":"Mahadev K, Motoshima H, Wu X, Ruddy JM, Arnold RS, Cheng G, Lambeth JD, Goldstein BJ: The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol\u200824:1844\u20131854,2004","DOI":"10.1128\/MCB.24.5.1844-1854.2004"},{"key":"2022031208444058300_R31","doi-asserted-by":"crossref","unstructured":"Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, Cros G, Azay J: Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis\u2008179:43\u201349,2005","DOI":"10.1016\/j.atherosclerosis.2004.10.018"},{"key":"2022031208444058300_R32","doi-asserted-by":"crossref","unstructured":"Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, Nawata H: Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med\u200837:115\u2013123,2004","DOI":"10.1016\/j.freeradbiomed.2004.04.001"},{"key":"2022031208444058300_R33","doi-asserted-by":"crossref","unstructured":"Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S: Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?J Clin Endocrinol Metab\u200886:3257\u20133265,2001","DOI":"10.1210\/jcem.86.7.7623"},{"key":"2022031208444058300_R34","doi-asserted-by":"crossref","unstructured":"Blackburn P, Lamarche B, Couillard C, Pascot A, Tremblay A, Bergeron J, Lemieux I, Despres JP: Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance. Diabetes Care\u200826:3303\u20133309,2003","DOI":"10.2337\/diacare.26.12.3303"},{"key":"2022031208444058300_R35","doi-asserted-by":"crossref","unstructured":"Cathcart MK: Regulation of superoxide anion production by NADPH oxidase in monocytes\/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol\u200824:23\u201328,2004","DOI":"10.1161\/01.ATV.0000097769.47306.12"},{"key":"2022031208444058300_R36","doi-asserted-by":"crossref","unstructured":"33. Pettit AI, Wong RKM, Lee V, Jennings S, Quinn PA, Ng LL: Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22phox in lymphoblast cell lines. J Hypertens\u200820:677\u2013683,2002","DOI":"10.1097\/00004872-200204000-00025"},{"key":"2022031208444058300_R37","doi-asserted-by":"crossref","unstructured":"San Jose\u0301 G, Moreno MU, Oliva\u0301n S, Beloqui O, Fortun\u0303o A, Di\u0301ez J, Zalba G: Functional effect of the p22phox -930A\/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension\u200844:163\u2013169,2004","DOI":"10.1161\/01.HYP.0000134790.02026.e4"},{"key":"2022031208444058300_R38","doi-asserted-by":"crossref","unstructured":"Laude K, Cai H, Fink B, Hoch N, Weber DS, McCann L, Kojda G, Fukai T, Schmidt HHHW, Dikalov S, Ramasamy S, Gamez G, Griendling KK, Harrison DG: Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol\u2008228:H7\u2013H12,2005","DOI":"10.1152\/ajpheart.00637.2004"},{"key":"2022031208444058300_R39","doi-asserted-by":"crossref","unstructured":"Brunzell JD, Ayyobi AF: Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med\u2008115 (Suppl. 8A):24S\u201328S,2003","DOI":"10.1016\/j.amjmed.2003.08.011"},{"key":"2022031208444058300_R40","doi-asserted-by":"crossref","unstructured":"Inoue I, Goto S, Matsunaga T, Nakajima T, Awata T, Hokari S, Komoda T, Katayama S: The ligands\/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism\u200850:3\u201311,2001","DOI":"10.1053\/meta.2001.19415"},{"key":"2022031208444058300_R41","doi-asserted-by":"crossref","unstructured":"Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C: Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia\u200844:834\u2013838,2001","DOI":"10.1007\/s001250100529"},{"key":"2022031208444058300_R42","doi-asserted-by":"crossref","unstructured":"Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D: Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest\u2008108:635\u2013636,2001","DOI":"10.1172\/JCI13727"},{"key":"2022031208444058300_R43","doi-asserted-by":"crossref","unstructured":"Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation\u2008106:1211\u20131218,2002","DOI":"10.1161\/01.CIR.0000027569.76671.A8"},{"key":"2022031208444058300_R44","doi-asserted-by":"crossref","unstructured":"Zouaoui Boudjeltia K, Moguilevsky N, Legssyer I, Babar S, Guillaume M, Delree P, Vanhaeverbeek M, Brohee D, Ducobu J, Remacle C: Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. Biochem Biophys Res Commun\u2008325:434\u2013438,2004","DOI":"10.1016\/j.bbrc.2004.10.049"},{"key":"2022031208444058300_R45","doi-asserted-by":"crossref","unstructured":"Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor WR, Griendling KK: Role of NADH\/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension\u200832:488\u2013495,1998","DOI":"10.1161\/01.HYP.32.3.488"},{"key":"2022031208444058300_R46","doi-asserted-by":"crossref","unstructured":"Quinones-Galvan A, Sironi AM, Baldi S, Galetta F, Garbin U, Fratta-Pasini A, Cominacini L, Ferrannini E: Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans. Arterioscler Thromb Vasc Biol\u200819:2928\u20132932,1999","DOI":"10.1161\/01.ATV.19.12.2928"},{"key":"2022031208444058300_R47","doi-asserted-by":"crossref","unstructured":"Mancini GB, Dahlof B, Diez J: Surrogate markers for cardiovascular disease: structural markers. Circulation\u2008109 (Suppl. IV):22\u201330,2004","DOI":"10.1161\/01.CIR.0000133443.77237.2f"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/55\/1\/209\/381971\/zdb00106000209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/55\/1\/209\/381971\/zdb00106000209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:28:04Z","timestamp":1667406484000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/55\/1\/209\/12349\/Phagocytic-NADPH-Oxidase-Overactivity-Underlies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.55.01.06.db05-0751","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}